PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral St., Glasgow G4 0RE, Scotland, UK; GSK, Siena, Italy.\', \'Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral St., Glasgow G4 0RE, Scotland, UK.\', \'Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral St., Glasgow G4 0RE, Scotland, UK; Department of Infectious Disease Immunology, Center for Vaccine Research, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen S, Denmark.\', \'GSK, Siena, Italy.\', \'GSK, Rockville, MD 9911, USA.\', \'Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral St., Glasgow G4 0RE, Scotland, UK. Electronic address: yvonne.perrie@strath.ac.uk.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0168-3659(21)00659-310.1016/j.jconrel.2021.12.008
?:doi
?:hasPublicationType
?:journal
  • Journal of controlled release : official journal of the Controlled Release Society
is ?:pmid of
?:pmid
?:pmid
  • 34896446
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potency.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34896446>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34896446>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all